PDE10A and Huntington disease: PET with the PDE10A ligand [18F]MNI‐659 in 45 subjects with HD, of whom 35 participated in the longitudinal phase and were scanned again at 18 months from baseline; subjects further underwent PET imaging of D2/3 receptors and structural MRI